Clinical Trial Update: Treatment With Erythropoietin and Cognition During Hypoglycaemia [NA]

View source ↗

Summary

An update on a trial evaluating erythropoietin for cognition during hypoglycemia in people with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Hillerod Hospital, Denmark | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: COMPLETED